These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 17311612)

  • 21. [Hepatitis C: epidemiology and therapy--with special reference to long-term prognosis after IFN therapy].
    Fujiyama S; Tanaka M
    Rinsho Byori; 2000 Jan; 48(1):5-13. PubMed ID: 10756668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of patients with hepatitis C virus-related hepatocellular carcinoma occurring after interferon therapy.
    Komorizono Y; Sako K; Yamasaki N; Hiwaki T; Sakurai K; Shibatou T; Maeda M; Kohara K; Shigenobu S; Hasegawa S; Arima T; Oketani M; Ishibashi K; Arima T
    Anticancer Res; 2002; 22(6B):3573-8. PubMed ID: 12552958
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Resected cases of hepatocellular carcinoma detected after interferon therapy for chronic hepatitis C.
    Kubo S; Nishiguchi S; Tamori A; Hirohashi K; Tanaka H; Tsukamoto T; Shuto T; Kuroki T; Kinoshita H
    Hepatogastroenterology; 2000; 47(34):1100-2. PubMed ID: 11020887
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term clinical outcome and effect of glycyrrhizin in 1093 chronic hepatitis C patients with non-response or relapse to interferon.
    Veldt BJ; Hansen BE; Ikeda K; Verhey E; Suzuki H; Schalm SW
    Scand J Gastroenterol; 2006 Sep; 41(9):1087-94. PubMed ID: 16938723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hepatocarcinoma in HCV compensated correlated liver cirrhosis: role of treatment with interferon].
    Testino G
    Recenti Prog Med; 2002 May; 93(5):302-7. PubMed ID: 12050912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Significance of hepatitis B virus DNA clearance and early prediction of hepatocellular carcinogenesis in patients with cirrhosis undergoing interferon therapy: long-term follow up of a pilot study.
    Ikeda K; Kobayashi M; Saitoh S; Someya T; Hosaka T; Akuta N; Suzuki Y; Suzuki F; Tsubota A; Arase Y; Kumada H
    J Gastroenterol Hepatol; 2005 Jan; 20(1):95-102. PubMed ID: 15610453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Interferon therapy to chronic hepatitis type C for the prevention of hepatocarcinogenesis].
    Ichida T; Ohkoshi S; Takimoto M; Ishikawa T
    Nihon Rinsho; 2001 Jul; 59(7):1331-7. PubMed ID: 11494547
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anticarcinogenic impact of interferon on patients with chronic hepatitis C: a large-scale long-term study in a single center.
    Ikeda K; Arase Y; Saitoh S; Kobayashi M; Someya T; Hosaka T; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Kumada H
    Intervirology; 2006; 49(1-2):82-90. PubMed ID: 16166794
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C.
    Hino K; Okita K
    J Antimicrob Chemother; 2004 Jan; 53(1):19-22. PubMed ID: 14657083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of metachronous cholangiocellular and hepatocellular carcinoma with good prognosis.
    Kosone T; Takagi H; Hamada T; Kakizaki S; Takehara K; Ohwada S; Mori M
    Hepatogastroenterology; 2005; 52(64):1228-32. PubMed ID: 16001668
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of long-term interferon therapy for refractory chronic hepatitis c: preventive effect on hepatocarcinogenesis.
    Saito Y; Saito H; Tada S; Nakamoto N; Horikawa H; Kurita S; Kitamura K; Ebinuma H; Ishii H; Hibi T
    Hepatogastroenterology; 2005; 52(65):1491-6. PubMed ID: 16201104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of interferon treatment response on liver complications of chronic hepatitis C: 9-year follow-up study.
    Coverdale SA; Khan MH; Byth K; Lin R; Weltman M; George J; Samarasinghe D; Liddle C; Kench JG; Crewe E; Farrell GC
    Am J Gastroenterol; 2004 Apr; 99(4):636-44. PubMed ID: 15089895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between infection with hepatitis C virus and hepatocellular carcinoma in Japan.
    Iino S
    Antivir Ther; 1998; 3(Suppl 3):143-6. PubMed ID: 10726064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical significance of interferon therapy in treatments for hepatitis C virus-related hepatocellular carcinoma].
    Kubo S; Nishiguchi S; Hirohashi K; Tanaka H; Shuto T; Takemura S; Shiomi S; Kinoshita H
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):1975-9. PubMed ID: 11791377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy.
    Taniguchi H; Iwasaki Y; Fujiwara A; Sakaguchi K; Moriya A; Yu PC; Takaki A; Fujioka S; Shimomura H; Shiratori Y
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):281-7. PubMed ID: 16460487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of interferon therapy on the incidence of hepatocellular carcinoma and mortality of patients with chronic hepatitis C: a retrospective cohort study of 738 patients.
    Tanaka H; Tsukuma H; Kasahara A; Hayashi N; Yoshihara H; Masuzawa M; Kanda T; Kashiwagi T; Inoue A; Kato M; Oshima A; Kinoshita Y; Kamada T
    Int J Cancer; 2000 Sep; 87(5):741-9. PubMed ID: 10925370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.
    Ikeda K; Saitoh S; Arase Y; Chayama K; Suzuki Y; Kobayashi M; Tsubota A; Nakamura I; Murashima N; Kumada H; Kawanishi M
    Hepatology; 1999 Apr; 29(4):1124-30. PubMed ID: 10094956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reduction therapy of alanine aminotransferase levels prevent HCC development in patients with HCV-associated cirrhosis.
    Rino Y; Tarao K; Morinaga S; Ohkawa S; Miyakawa K; Hirokawa S; Masaki T; Tarao N; Yukawa N; Saeki H; Takanashi Y; Imada T
    Anticancer Res; 2006; 26(3B):2221-6. PubMed ID: 16821591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis.
    Arrieta O; Rodriguez-Diaz JL; Rosas-Camargo V; Morales-Espinosa D; Ponce de Leon S; Kershenobich D; Leon-Rodriguez E
    Cancer; 2006 Oct; 107(8):1852-8. PubMed ID: 16967451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Biochemical and histologic changes in patients with chronic hepatitis C under treatment with interferon. a 5-year cohort study].
    Dávila-Fernández BC; Santiago-Luna E; Navarro-López R; Moreno Villa HR; Cumplido-Hernández G
    Rev Gastroenterol Mex; 2003; 68(1):16-22. PubMed ID: 12940094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.